Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 406

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 406
---
 and the like) for any
20 trading days within any 30-trading day period commencing after our initial business combination and (ii) with respect to the remaining
50% of the founder shares and Private Placement Units, six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a liquidation, merger, share exchange or
other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities
or other property, except in each case (a) to our officers or directors, any affiliates or family members of any of our officers or directors,
any members of our sponsor, or any affiliates of our sponsor, (b) in the case of an individual, by gift to a member of the individual’s
immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such
person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of
the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) transfers by private sales or
transfers made in connection with consummation of a business combination at prices no greater than the price at which the securities were
originally purchased; (f) in the event of our liquidation prior to our completion of our initial business combination; (g) by virtue of
the laws of Delaware or our sponsor’s limited liability company agreement, as amended, upon dissolution of our sponsor; (h) in the
event of our completion of a liquidation, merger, share exchange, reorganization or other similar transaction which results in all of
our public shareholders having the right to exchange their ordinary shares for cash, securities or other property subsequent to our completion
of our initial business combination; or (i) to a nominee or custodian of a person or entity to whom a disposition or transfer would be
permissible under clauses (a) through (h) above; provided, however, that in the case of clauses (a) through (e) and (i) these permitted
transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained
in the letter agreement. In addition, we could agree to permit the holders of our founder shares to transfer shares or